KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 114 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $456,000 | -77.2% | 29,429 | -71.7% | 0.09% | -81.2% |
| Q4 2019 | $1,996,000 | +77.0% | 104,100 | -11.2% | 0.49% | +56.2% |
| Q3 2019 | $1,128,000 | -64.3% | 117,250 | -77.7% | 0.31% | -64.9% |
| Q2 2019 | $3,156,000 | +21.5% | 526,900 | +18.4% | 0.89% | +13.6% |
| Q1 2019 | $2,598,000 | -37.7% | 444,900 | 0.0% | 0.79% | -47.4% |
| Q4 2018 | $4,169,000 | -48.3% | 444,900 | -6.1% | 1.50% | -32.9% |
| Q3 2018 | $8,071,000 | +13.9% | 473,901 | +13.7% | 2.23% | +0.4% |
| Q2 2018 | $7,083,000 | – | 416,900 | – | 2.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |